Currently, the stock price of eFFECTOR Therapeutics Inc. (EFTR) is $0.61. In the most recent trading session, the stock underwent a significant upswing, peaking at $0.65 after opening at $0.6294. The stock touched a low of $0.61 before closing at $0.64.
In terms of market performance, eFFECTOR Therapeutics Inc. had a somewhat inconsistent run in. The highest value for the stock in the past year was $1.48 on 06/06/23, while the lowest value was $0.34 on 03/30/23.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
52-week price history of EFTR Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. eFFECTOR Therapeutics Inc.’s current trading price is -58.68% away from its 52-week high, while its distance from the 52-week low is 81.05%. The stock’s price range for this period has remained between $0.34 and $1.48. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.52 million for the day, which was noticeably lower compared to the shares’ average daily volume of 0.8 million over the last three months.
Financial Performance and Market Capitalization
eFFECTOR Therapeutics Inc. (EFTR) has experienced a quarterly decline of -46.82% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 39.10M and boasts a workforce of 15 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7443, with a change in price of +0.2066. Similarly, eFFECTOR Therapeutics Inc. recorded 1,541,777 in trading volume during the last 100 days, posting a change of +51.01%.
EFTR Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for EFTR stands at 7.38. Similarly, the long-term debt-to-equity ratio is also 0.00.
EFTR Stock Stochastic Average
As of today, the raw stochastic average of eFFECTOR Therapeutics Inc. over the last 50 days is at 3.22%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 0.94%. Further, the company’s Stochastic %K and %D values for the last 20 days were 11.68% and 14.95%, respectively.
EFTR Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. This year’s metric has recorded a Price increase of 43.03%. However, over the past six months, we’ve seen a weaker performance of 52.90%. The price of EFTR leaped by -9.94% over the last 30 days. And in the last five days, it has fallen by -8.63%.
